Prevagen is unlikely to benefit your brain in any meaningful way. Despite being one of the best-selling memory supplements in the United States, the active ingredient has no high-quality evidence supporting its use for memory, cognition, or brain health. The protein it contains is almost certainly digested in your stomach before it ever reaches your brain, and the Federal Trade Commission has successfully sued its manufacturer for making false advertising claims.
What Prevagen Claims to Do
Prevagen’s active ingredient is apoaequorin, a calcium-binding protein originally found in a species of jellyfish. The manufacturer, Quincy Bioscience, markets it as a supplement that supports brain cell health by helping regulate calcium levels inside neurons. The idea sounds plausible on the surface: calcium signaling is genuinely important for brain cell survival and communication, and disruptions in calcium balance do play a role in age-related cognitive decline.
The product comes in two strengths, a 10 mg regular version and a 20 mg “extra strength” version, both taken as a daily capsule or chewable tablet. Prices typically run $40 to $60 for a month’s supply.
The Digestion Problem
The most fundamental issue with Prevagen is biological. Apoaequorin is a protein, and your digestive system is specifically designed to break proteins apart. Research published in Regulatory Toxicology and Pharmacology confirmed that apoaequorin is easily digested by pepsin, the enzyme in your stomach acid. This is normal behavior for dietary proteins. Once broken down into amino acids, those fragments are no different from the amino acids in any food you eat.
Even if apoaequorin somehow survived digestion intact, it would face another barrier. The blood-brain barrier is a tightly controlled membrane that prevents most substances in your bloodstream from entering your brain. It selectively allows small, fat-soluble molecules through, typically those under 400 to 500 daltons in molecular weight. Apoaequorin has a molecular weight of 22,000 daltons and is not fat-soluble. It is roughly 50 times too large to cross into the brain. So the protein cannot survive your stomach, and even if it could, it almost certainly cannot reach the organ it’s supposed to help.
What the Clinical Evidence Actually Shows
The manufacturer’s primary evidence is the “Madison Memory Study,” a 90-day trial of 218 adults over age 40. It was designed as a randomized, double-blind, placebo-controlled study, which is the right framework. But the results tell a more complicated story than the advertising suggests.
When looking at the full study population, Prevagen did not outperform the placebo on the study’s primary measures. The positive results the company highlights came from post-hoc subgroup analyses, meaning researchers went back after the trial ended and sliced the data into smaller groups until they found one where the supplement appeared to work. This is a well-known statistical problem. When you test enough subgroups, some will show positive results by chance alone. These kinds of findings are considered hypothesis-generating at best, not proof that a treatment works.
The MSD Manuals, a widely used medical reference, states plainly that there are no high-quality studies demonstrating apoaequorin is effective for improving memory loss or treating any health condition. No independent research team, unaffiliated with the manufacturer, has published evidence that Prevagen works.
The FTC Lawsuit
In a case that concluded in December 2024, the Federal Trade Commission and the New York State Attorney General charged Quincy Bioscience with making false and unsubstantiated claims that Prevagen improves memory, provides cognitive benefits, and is “clinically shown” to work. The FTC won the lawsuit. The agency’s core argument was that the company’s own clinical trial did not support the broad claims made in its advertising.
Safety Concerns
Prevagen is generally presented as harmless, but the safety record is not as clean as the marketing suggests. Thousands of Americans have reported adverse events while taking the supplement, including seizures, strokes, heart rhythm problems, chest pain, and dizziness. A 2015 internal company report acknowledged that the “numerous adverse events reported” indicated “a serious safety hazard.”
A Wired investigation found that Quincy Bioscience failed to report at least 24 potentially serious adverse events to the FDA. An FDA inspection uncovered 18 additional cases the company had decided not to classify as serious, including five reports of seizures, three strokes or mini-strokes, and four episodes of vertigo or falling that required medical attention. One consumer reported that after starting Prevagen, their seizure frequency increased from rare occurrences to four or five times per week.
It is difficult to know whether Prevagen directly caused these events or whether they were coincidental, particularly in an older population already at higher risk for strokes and seizures. But the pattern of underreporting is concerning on its own.
What Experts Say About Brain Supplements
The skepticism around Prevagen extends to memory supplements as a category. Pieter Cohen, an internist at Harvard-affiliated Cambridge Health Alliance who researches dietary supplements extensively, has been direct: nothing legally contained in supplements has been proven to improve thinking or prevent memory loss. This includes omega-3 fatty acids, which are often marketed for brain health but lack convincing evidence for cognitive benefits in supplement form.
Because supplement manufacturers can advertise without proving their claims work, the language on product labels is essentially unregulated marketing copy. The FDA does not approve dietary supplements for effectiveness before they reach store shelves. This is fundamentally different from prescription drugs, which must demonstrate efficacy in clinical trials before approval.
What Actually Supports Brain Health
The interventions with the strongest evidence for maintaining cognitive function as you age are not supplements. Regular aerobic exercise consistently shows benefits for memory and executive function in clinical research. Sleep quality matters enormously, as the brain clears waste products during deep sleep that are associated with neurodegenerative disease. Social engagement, managing cardiovascular risk factors like high blood pressure and diabetes, and staying mentally active all have stronger evidence behind them than any pill currently sold over the counter.
A Mediterranean-style diet rich in vegetables, fish, nuts, and olive oil has been linked to slower cognitive decline in large observational studies. The nutrients in whole foods are absorbed and used by the body far more effectively than isolated compounds in capsule form, and they come with none of the regulatory uncertainty of the supplement industry.